210 related articles for article (PubMed ID: 10452629)
1. Evolution of vaginal Candida species recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis: the emergence of Candida glabrata? Terry Beirn Community Programs for Clinical Research in AIDS (CPCRA).
Vazquez JA; Sobel JD; Peng G; Steele-Moore L; Schuman P; Holloway W; Neaton JD
Clin Infect Dis; 1999 May; 28(5):1025-31. PubMed ID: 10452629
[TBL] [Abstract][Full Text] [Related]
2. Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis.
Vazquez JA; Peng G; Sobel JD; Steele-Moore L; Schuman P; Holloway W; Neaton JD
Clin Infect Dis; 2001 Oct; 33(7):1069-75. PubMed ID: 11528582
[TBL] [Abstract][Full Text] [Related]
3. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A;
J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125
[TBL] [Abstract][Full Text] [Related]
4. Weekly fluconazole for the prevention of mucosal candidiasis in women with HIV infection. A randomized, double-blind, placebo-controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS.
Schuman P; Capps L; Peng G; Vazquez J; el-Sadr W; Goldman AI; Alston B; Besch CL; Vaughn A; Thompson MA; Cobb MN; Kerkering T; Sobel JD
Ann Intern Med; 1997 May; 126(9):689-96. PubMed ID: 9139554
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.
Ray D; Goswami R; Banerjee U; Dadhwal V; Goswami D; Mandal P; Sreenivas V; Kochupillai N
Diabetes Care; 2007 Feb; 30(2):312-7. PubMed ID: 17259500
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of recurrent vulvovaginal candidosis with mycosyst (fluconazole)].
Pekhlivanov B; Amaliev I; Ivancheva Kh; Zisova L
Akush Ginekol (Sofiia); 2005; 44 Suppl 2():25-7. PubMed ID: 16028400
[TBL] [Abstract][Full Text] [Related]
7. Fluconazole vs. flucytosine in the treatment of esophageal candidiasis in AIDS patients: a double-blind, placebo-controlled study.
Barbaro G; Barbarini G; Di Lorenzo G
Endoscopy; 1995 Jun; 27(5):377-83. PubMed ID: 7588352
[TBL] [Abstract][Full Text] [Related]
8. Treatment of complicated Candida vaginitis: comparison of single and sequential doses of fluconazole.
Sobel JD; Kapernick PS; Zervos M; Reed BD; Hooton T; Soper D; Nyirjesy P; Heine MW; Willems J; Panzer H; Wittes H
Am J Obstet Gynecol; 2001 Aug; 185(2):363-9. PubMed ID: 11518893
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of fluconazole and nystatin in the treatment of vaginal Candida species.
Martins HP; da Silva MC; Paiva LC; Svidzinski TI; Consolaro ME
Acta Derm Venereol; 2012 Jan; 92(1):78-82. PubMed ID: 21918792
[TBL] [Abstract][Full Text] [Related]
10. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis.
Sobel JD; Wiesenfeld HC; Martens M; Danna P; Hooton TM; Rompalo A; Sperling M; Livengood C; Horowitz B; Von Thron J; Edwards L; Panzer H; Chu TC
N Engl J Med; 2004 Aug; 351(9):876-83. PubMed ID: 15329425
[TBL] [Abstract][Full Text] [Related]
11. Karyotyping of Candida albicans and Candida glabrata isolates from recurrent vaginal infections by pulsed-field gel electrophoresis.
Fodor E; Dósa E; Nagy A; Nagy E; Ferenczy L
Acta Microbiol Immunol Hung; 2002; 49(1):59-68. PubMed ID: 12073826
[TBL] [Abstract][Full Text] [Related]
12. Post-menopausal recurrent vaginal candidiasis: effect of hysterectomy on response to treatment, type of colonization and recurrence rates post-treatment.
Ventolini G; Baggish MS
Maturitas; 2005 Jul; 51(3):294-8. PubMed ID: 15978973
[TBL] [Abstract][Full Text] [Related]
13. The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial.
Magill SS; Swoboda SM; Shields CE; Colantuoni EA; Fothergill AW; Merz WG; Lipsett PA; Hendrix CW
Ann Surg; 2009 Apr; 249(4):657-65. PubMed ID: 19300221
[TBL] [Abstract][Full Text] [Related]
14. [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use].
Saporiti AM; Gómez D; Levalle S; Galeano M; Davel G; Vivot W; Rodero L
Rev Argent Microbiol; 2001; 33(4):217-22. PubMed ID: 11833253
[TBL] [Abstract][Full Text] [Related]
15. Vulvovaginal candidiasis in a Flemish patient population.
De Vos MM; Cuenca-Estrella M; Boekhout T; Theelen B; Matthijs N; Bauters T; Nailis H; Dhont MA; Rodriguez-Tudela JL; Nelis HJ
Clin Microbiol Infect; 2005 Dec; 11(12):1005-11. PubMed ID: 16307555
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal study of mucosal Candida species colonization and candidiasis among human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
Ohmit SE; Sobel JD; Schuman P; Duerr A; Mayer K; Rompalo A; Klein RS;
J Infect Dis; 2003 Jul; 188(1):118-27. PubMed ID: 12825180
[TBL] [Abstract][Full Text] [Related]
17. Molecular typing and in vitro fluconazole susceptibility of Candida species isolated from diabetic and nondiabetic women with vulvovaginal candidiasis in India.
Lattif AA; Mukhopadhyay G; Banerjee U; Goswami R; Prasad R
J Microbiol Immunol Infect; 2011 Jun; 44(3):166-71. PubMed ID: 21524609
[TBL] [Abstract][Full Text] [Related]
18. [Oesophageal candidiasis: clinical and mycological analysis].
Olmos MA; Araya V; Concetti H; Ramallo J; Piskorz E; Pérez H; Cahn P; Kaufman S; Guelfand L
Acta Gastroenterol Latinoam; 2005; 35(4):211-8. PubMed ID: 16496852
[TBL] [Abstract][Full Text] [Related]
19. Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of <1000 grams birth weight.
Kaufman D; Boyle R; Hazen KC; Patrie JT; Robinson M; Grossman LB
J Pediatr; 2005 Aug; 147(2):172-9. PubMed ID: 16126045
[TBL] [Abstract][Full Text] [Related]
20. Immune compromise and prevalence of Candida vulvovaginitis in human immunodeficiency virus-infected women.
Duerr A; Sierra MF; Feldman J; Clarke LM; Ehrlich I; DeHovitz J
Obstet Gynecol; 1997 Aug; 90(2):252-6. PubMed ID: 9241304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
